Zobrazeno 1 - 10 of 13 pro vyhledávání: '"Garima Shrivastava"'
1
Akademický článek
An updated management approach of Pompe disease patients with high-sustained anti-rhGAA IgG antibody titers: experience with bortezomib-based immunomodulation
Autor: Ankit K. Desai, Garima Shrivastava, Christina L. Grant, Raymond Y. Wang, Trevor D. Burt, Priya S. Kishnani
Publikováno v: Frontiers in Immunology, Vol 15 (2024)
IntroductionHigh sustained anti-rhGAA antibody titers (HSAT; ≥12,800) are directly linked to reduced efficacy of enzyme replacement therapy (ERT) and subsequent clinical deterioration in infantile-onset Pompe disease (IOPD). We have previously demo
Externí odkaz: https://doaj.org/article/feaa2ff9617e4639b0282d4875ed2de3
Zobrazit plný text záznamu
2
Bijji’s Tale from Duvidha to Paheli: Journey of a Folklore
Autor: Garima Shrivastava
Publikováno v: Journal of Communication and Management. 2:19-22
Padam Shree Vijaydan Detha, popularly known as ‘Bijji’ is a renowned Rajasthani folklore writer, and Rajasthan is the land of colors of folklores, art, and cultural tradition. Every particle of sand tells a story of romance, bravery, and sacrific
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5aaafe40a83efe03b3513fb3c9edf80b
https://doi.org/10.58966/jcm2023213
Zobrazit plný text záznamu
3
Nucleic Acid Aptamers as a Potential Nucleus Targeted Drug Delivery System
Autor: Murtaza M. Tambuwala, Nitin Charbe, Garima Shrivastava, Kamal Dua, Vijay Mishra, Faruck Lukmanul Hakkim, Alaa A. A. Aljabali, Prashant Kesharwani, Hamid A. Bakshi, Dinesh Kumar Chellappan
Publikováno v: Current Drug Delivery. 17:101-111
Background: Nucleus targeted drug delivery provides several opportunities for the treatment of fatal diseases such as cancer. However, the complex nucleocytoplasmic barriers pose significant challenges for delivering a drug directly and efficiently i
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c358aea0cdc850099d1d04271ead0b9
https://doi.org/10.2174/1567201817666200106104332
Zobrazit plný text záznamu
4
Overview of key molecular and pharmacological targets for diabetes and associated diseases
Autor: Vijay Mishra, Nitin B Charbe, Yogendra Kumar Mishra, Marzieh Lotfi, Murtaza M. Tambuwala, Kamal Dua, Gaurav Gupta, Ángel Serrano-Aroca, Debmalya Barh, Pritam Kumar Panda, Hamid A. Bakshi, Dinesh Kumar Chellappan, Abdullah M Alnuqaydan, Seyed Hossein Shahcheraghi, Yusuf A. Haggag, Alaa A. A. Aljabali, Garima Shrivastava, Abdulmajeed G Almutary, Mazhar Salim Al Zoubi, Kazuo Takayama, Bojlul Bahar
Publikováno v: Shahcheraghi, S H, Aljabali, A A A, Al Zoubi, M S, Mishra, V, Charbe, N B, Haggag, Y A, Shrivastava, G, Almutary, A G, Alnuqaydan, A M, Barh, D, Dua, K, Chellappan, D K, Gupta, G, Lotfi, M, Serrano-Aroca, Á, Bahar, B, Mishra, Y K, Takayama, K, Panda, P K, Bakshi, H A & Tambuwala, M M 2021, ' Overview of key molecular and pharmacological targets for diabetes and associated diseases ', Life Sciences, vol. 278, 119632 . https://doi.org/10.1016/j.lfs.2021.119632
Diabetes epidemiological quantities are demonstrating one of the most important communities' health worries. The essential diabetic difficulties are including cardiomyopathy, nephropathy, inflammation, and retinopathy. Despite developments in glucose
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d979ff56cf7af57c2cc810024c7b4d58
Zobrazit plný text záznamu
5
Dynamics of Prolyl Hydroxylases Levels During Disease Progression in Experimental Colitis
Autor: Hamid A. Bakshi, Dinesh Kumar Chellappan, Nitin Charbe, Bahaa Al-Trad, Shanmugam Rajeshkumar, Prashant Kesharwani, Kavita Pabreja, Alaa A. A. Aljabali, Murtaza M. Tambuwala, Faruk L. Hakkim, Meenu Mehta, Saurabh Satija, Garima Shrivastava, Vijay Mishra, Kamal Dua
Publikováno v: Inflammation
Hypoxia inducible factor (HIF)-prolyl hydroxylase (PHD) inhibitors are shown to be protective in several models of inflammatory bowel disease (IBD). However, these non-selective inhibitors are known to inhibit all the three isoforms of PHD, i.e. PHD-
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f88c9db1b504f4b7c7636e09a7345e0
https://doi.org/10.1007/s10753-019-01065-3
Zobrazit plný text záznamu
7
Small interfering RNA for cancer treatment: overcoming hurdles in delivery
Autor: Alaa A. A. Aljabali, Nitin Charbe, Poonam Negi, Nikhil D. Amnerkar, Gaurav Gupta, B. Ramesh, Meenu Metha, Hamid A. Bakshi, Dinesh Kumar Chellappan, Saurabh C. Khadse, Garima Shrivastava, Saurabh Satija, Kamal Dua, Flavia C. Zacconi, Murtaza M. Tambuwala, Rajendran Satheeshkumar
Publikováno v: Acta Pharmaceutica Sinica. B
In many ways, cancer cells are different from healthy cells. A lot of tactical nano-based drug delivery systems are based on the difference between cancer and healthy cells. Currently, nanotechnology-based delivery systems are the most promising tool
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2071f422f1c1f8a688b18780d3afbc9c
https://pubmed.ncbi.nlm.nih.gov/33304780
Zobrazit plný text záznamu
10
Microwave Assisted Synthesis and Characterization of Schiff Base of 2-Amino Benzimidazole
Autor: Manjul Shrivastava, Garima Shrivastava
Publikováno v: International Journal of Pharmaceutical Sciences and Drug Research. 10
New Schiff base (2-[(1H-benzimidazol-2-ylimino) methyl]-4,6- diiodophenol) was synthesized by the condensation of aryl/hetero aromatic aldehyde (3,5diiodosalicylaldehyde) with 2- amino benzimidazole under conventional and microwave conditions and cha
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::965721c28e4490ffd84611f838b958ca
https://doi.org/10.25004/ijpsdr.2018.100414
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje